ClinicalTrials.Veeva

Menu

Electroretinography: Investigation of a Protocol Change (SHERG)

NHS Trust logo

NHS Trust

Status

Unknown

Conditions

Dark-adapted ERG

Treatments

Diagnostic Test: Electroretinography

Study type

Observational

Funder types

Other

Identifiers

NCT03275441
GN17OP146

Details and patient eligibility

About

The study evaluates whether an eye test called an electroretinogram (ERG) can be shortened and still produce the same diagnostic results. The results of this study may allow test times to be reduced which will have benefits such as improved patient compliance during shorter testing and increased clinic efficiency.

Full description

A full-field electroretinogram (ERG) is a standardised eye test undertaken in specialist hospital clinics. ERGs are useful for diagnosing and monitoring retinal diseases. The retina is stimulated by showing patients flashes of light and the resulting electrical response from the eye is recorded using delicate electrodes that touch the surface of the eye. For the first section of the test, patient's eyes are allowed to adjust to the dark to ensure the parts of the retina responsible for seeing in dimly-lit conditions are being tested.

The international ERG Standard says patients must sit in the dark for 20 minutes. The investigators have evidence to suggest the test may be equally useful after only 10 minutes in the dark. The investigators plan to compare ERGs recorded from patients who have spent only 10 minutes in the dark with ERGs recorded from the same patients after the full 20 minutes in the dark. If the difference is suitably small, as found in a preliminary study of healthy individuals, it could be justifiable to shorten the routine patient protocol.

Subjects for this study will be recruited from the adult population routinely attending for an outpatient ERG test. During their routine ERG test, 10 minutes into the 20 minute wait in the dark, the investigators propose recording an additional, identical set of ERG tests. This will not add extra time to the clinical test.

Participants will not need any follow-up for the research study. The study requires 262 patients to test the hypothesis, and the investigators estimate this will take about 5-6 months.

Enrollment

262 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients referred to the adult visual electrophysiology service regardless of clinical condition, and who require dark-adapted electroretinography as part of their appointment
  • Male or female
  • All ethnicities

Exclusion criteria

  • Patients less than 18 years old
  • Patients who might have difficulties understanding the participant information provided (for example, those patients requiring a translator, or who have learning difficulties)
  • Patients with photosensitive epilepsy
  • Patients appointed for clinical testing urgently, or via telephone, who will not have had an opportunity to receive and review the participant information sheet ahead of the clinical appointment.

Trial design

262 participants in 1 patient group

Adult patients
Description:
Adult patients attending hospital for clinical visual electrophysiology.
Treatment:
Diagnostic Test: Electroretinography

Trial contacts and locations

0

Loading...

Central trial contact

Kirsten Graham, MSc; Ruth Hamilton, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems